Trialists’ Intent to Share Individual Participant Data as Disclosed at ClinicalTrials.gov
Open Access
- 23 January 2018
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 319 (4) , 406-408
Abstract
The US Institute of Medicine and the International Committee of Medical Journal Editors (ICMJE), among others, have called for clinical trialists to declare their plans to share individual participant data (IPD) and related study documents for secondary research prior to study initiation.1-3 Individual participant data, which refers to measurements collected from each research participant, is distinct from aggregated data usually reported in journal articles or in the ClinicalTrials.gov results database.1 The term IPD sharing refers to the practice of making clinical trial data at the individual level available to researchers who were not part of the original study team.4Keywords
This publication has 5 references indexed in Scilit:
- Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal EditorsAnnals of Internal Medicine, 2017
- Data Sharing Statements for Clinical TrialsJAMA, 2017
- Sharing of Data From Industry-Funded Registered Clinical TrialsJAMA, 2016
- Data SharingJAMA, 2016
- Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)PLOS Medicine, 2016